Torrent Pharmaceuticals Ltd. (TORP)

NSE


	Symbol		Exchange		Currency
	TORP		NSE		INR	Real-time
	TORPc1:NS		NSE		INR	Delayed
	TORPc2:NS		NSE		INR	Delayed
	TORP		BSE		INR	Delayed

Currency in INR

3,178.60

-36.45(-1.13%)

Closed04:59:59

Fair Value

Day's Range

3,151.85

3,244.00

52 wk Range

2,407.25

3,590.70

TORP Income Statement

Featured here, the Income Statement (earnings report) for Torrent Pharmaceuticals Ltd., showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

79,393.1

80,045.7

85,080.4

96,201.5

107,278.4

Total Revenues Growth

+3.47%

+0.82%

+6.29%

+13.07%

+11.51%

Cost Of Revenues

21,669.2

21,464.2

24,420.1

27,351.9

26,862.1

Gross Profit

57,723.9

58,581.5

60,660.3

68,849.6

80,416.3

Gross Profit Growth

+5.86%

+1.49%

+3.55%

+13.5%

+16.8%

Gross Profit Margin %

72.71%

73.19%

71.3%

71.57%

74.96%

Other Operating Expenses, Total

42,535.4

40,353.8

42,966.9

47,449.4

54,692.8

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+4.14%	-5.13%	+6.48%	+10.43%	+15.27%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14,421.2	14,596.9	15,482.9	17,051.8	20,166.4
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	21,599.1	19,183.8	20,864.7	23,377.3	26,573.4

Operating Income

15,188.5

18,227.7

17,693.4

21,400.2

25,723.5

Operating Income Growth

+10.97%

+20.01%

-2.93%

+20.95%

+20.2%

EBIT Margin %

19.13%

22.77%

20.8%

22.25%

23.98%

Net Interest Expenses

-4,404

-3,457.5

-2,457.8

-3,174.6

-3,411.5

Net Interest Expenses Growth

+9.14%

+21.49%

+28.91%

-29.16%

-7.46%

Interest Expense, Total

-4,483.6

-3,508.2

-2,529.3

-3,322.4

-3,526.3

Interest And Investment Income

79.6

50.7

71.5

147.8

114.8

Other Non Operating Expenses, Total

817.9

341.4

1,771.4

-119.7

275.3

EBT, Excl. Unusual Items

11,602.4

15,111.6

17,007

18,105.9

22,587.3

Gain (Loss) On Sale Of Assets

-

-

-

216.2

-0.2

Other Unusual Items, Total

-28.7

-4.8

-2.3

-45.6

754.1

EBT, Incl. Unusual Items

11,865.7

15,262.6

12,259.1

18,471.6

23,521.1

EBT, Incl. Unusual Items Growth

+111.26%

+28.63%

-19.68%

+50.68%

+27.34%

EBT, Incl. Unusual Items Margin

14.95%

19.07%

14.41%

19.2%

21.93%

Income Tax Expense

1,618.5

2,743.8

4,487.3

6,019.3

6,957.3

Net Income to Company

10,247.2

12,518.8

7,771.8

12,452.3

16,563.8

Minority Interest

-

-

-

-

-

Net Income

10,247.2

12,518.8

7,771.8

12,452.3

16,563.8

Net Income Growth

+134.88%

+22.17%

-37.92%

+60.22%

+33.02%

Net Income Margin %

12.91%

15.64%

9.13%

12.94%

15.44%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

10,247.2

12,518.8

7,771.8

12,452.3

16,563.8

Basic EPS - Continuing Operations

30.28

36.99

22.96

36.79

48.94

Basic EPS - Continuing Operations Growth

+134.88%

+22.17%

-37.92%

+60.22%

+33.02%

Diluted EPS - Continuing Operations

30.28

36.99

22.96

36.79

48.94

Diluted EPS - Continuing Operations Growth

+134.88%

+22.17%

-37.92%

+60.22%

+33.02%

Basic Weighted Average Shares Outstanding

338.45

338.45

338.45

338.45

338.45

Diluted Weighted Average Shares Outstanding

338.45

338.45

338.45

338.45

338.45

Dividend Per Share

8.5

17.5

16.5

22

28

Dividend Per Share Growth

0%

+105.88%

-5.71%

+33.33%

+27.27%

EBITDA

21,179.6

24,290.5

23,823.1

28,026.4

33,249

EBITDA Growth

+7.99%

+14.69%

-1.92%

+17.64%

+18.63%

EBITDA Margin %